Clinical Research: Phase 1 - Phase 4
Regulatory Considerations for Radiotherapeutics and Radiodiagnostics
Scientific innovation and advances in ligand targeting have spurred the development of many different types of radiopharmaceutical (RPs) – radioisotopes bound to biological molecules to target specific organs, tissues, or cells within the body — with a wide range of clinical uses. As those uses have proliferated, and as research has continued to yield novel...